The
fungal infection invasive aspergillosis (IA) can be life threatening,
especially in patients whose immune systems are weakened by chemotherapy or
immunosuppressive drugs. IA is difficult to diagnose and it is caused by the
fungus Aspergillus fumigatus.
A
recent study compared three diagnostic tests and found that the combination of
nucleic acid sequence-based amplification (NASBA) and real-time quantitative
PCR (qPCR) detects aspergillosis with a high degree of accuracy.
For
this, researchers evaluated the diagnostic performance of two nucleic acid
amplification assays (qPCR and NASBA) and one antigen detection method
(galactomannan enzyme-linked immunosorbent assay [GM-ELISA]) using blood
samples collected from 80 patients at high risk of IA.
Data
analysis showed that the combination of NASBA and qPCR led to 100% specificity
and 100% positive predictive value (the probability that subjects truly have
the infection).
The
reference is:
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources